Pfizer's Covid Antiviral Pill May Cut Severe Illness By 89 Percent
The drugmaker said its studies of the pill were so successful that it stopped clinical trials early.
The drugmaker said its studies of the pill were so successful that it stopped clinical trials early.
In parts of the country where covid-19 continues to fill hospitals, a rotating cast of traveling nurses helps keep intensive care units fully staffed. Hospitals have to pay handsomely to get that temporary help, and those higher wages are tempting some staff nurses to hit the road, too.
People inoculated against Covid-19 are just as likely to spread the delta variant of the virus to contacts in their household as those who haven’t had shots, according to new research.
Hospitals nationwide are trying to address nurse shortages by hiring new graduates. However, becoming a nurse has become more challenging, narrowing the pipeline for new nurses.
In this small town I live in, a funeral procession is a big deal. The hearse is followed by several black cars turning into an array of family and friends cars. All of them roll slowly and sadly to the final destination.
Research has found that having children is terrible for quality of life—but the truth about what parenthood means for happiness is a lot more complicated.
Certain immunocompromised people can now receive, and in some cases should receive, a fourth dose of COVID-19 vaccine, the CDC said in updated interim clinical guidance this week.
Patients are flocking to the first new obesity medicine to reach the market in years, boosting returns for drugmaker Novo Nordisk A/S.
Masthead
Editor-in Chief:
Kirsten Nicole
Editorial Staff:
Kirsten Nicole
Stan Kenyon
Robyn Bowman
Kimberly McNabb
Lisa Gordon
Stephanie Robinson
Contributors:
Kirsten Nicole
Stan Kenyon
Liz Di Bernardo
Cris Lobato
Elisa Howard
Susan Cramer